Study to Evaluate Vadadustat for Anemia in Subjects With Dialysis-Dependent Chronic Kidney Disease (DD-CKD) Who Are Hyporesponsive to Erythropoiesis Stimulating Agents
Public ClinicalTrials.gov record NCT03140722. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase 2, Randomized, Open-Label Study Evaluating the Efficacy and Safety of Oral Vadadustat for the Treatment of Anemia in Subjects With Dialysis-Dependent Chronic Kidney Disease (DD-CKD) Who Are Hyporesponsive to Erythropoiesis Stimulating Agents
Study identification
- NCT ID
- NCT03140722
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Akebia Therapeutics
- Industry
- Enrollment
- 2 participants
Conditions and interventions
Conditions
Interventions
- vadadustat Drug
- epoetin alfa Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 1, 2017
- Primary completion
- Mar 20, 2018
- Completion
- Mar 20, 2018
- Last update posted
- Feb 20, 2021
2017 – 2018
United States locations
- U.S. sites
- 18
- U.S. states
- 9
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Bakersfield | California | 93309 | — |
| Research Site | Elk Grove | California | 95758 | — |
| Research Site | Encino | California | 91316 | — |
| Research Site | Escondido | California | 92025 | — |
| Research Site | Lynwood | California | 90262 | — |
| Research Site | San Diego | California | 92115 | — |
| Research Site | San Luis Obispo | California | 93401 | — |
| Research Site | Waterbury | Connecticut | 06708 | — |
| Research Site | Miami | Florida | 33183 | — |
| Research Site | Orlando | Florida | 32804 | — |
| Research Site | Statesboro | Georgia | 30458 | — |
| Research Site | Detroit | Michigan | 48224 | — |
| Research Site | The Bronx | New York | 10473 | — |
| Research Site | Philadelphia | Pennsylvania | 19106 | — |
| Research Site | El Paso | Texas | 79915 | — |
| Research Site | Houston | Texas | 77070 | — |
| Research Site | Newport News | Virginia | 23605 | — |
| Research Site | Norfolk | Virginia | 23502 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03140722, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 20, 2021 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03140722 live on ClinicalTrials.gov.